San Diego Biotech News
Thursday, July 2nd, 2009
Source: San Diego Union Tribune
Concert promoter AEG Live's chief executive said Thursday that insurance will help cover any losses on the now-canceled Michael Jackson concert series if the pop star died accidentally _ including of a drug overdose _ but not if he died of natural causes.
Posted in San Diego Biotech News, San Diego Union Tribune, Syndication | Comments Off
Thursday, July 2nd, 2009
Source: San Diego Union Tribune
Johnson & Johnson, making a big jump into the risky but potentially lucrative field of Alzheimer's disease, is taking a major stake in Irish biopharmaceutical company Elan Corp., investing up to $1.5 billion initially.
Posted in San Diego Biotech News, San Diego Union Tribune, Syndication | Comments Off
Thursday, July 2nd, 2009
Source: Xconomy San Diego
We had a mixed bag of bad and good news from the San Diego life sciences industry this week heading into the holiday weekend.
—At least 11 shareholder lawsuits have been filed against San...
[[Click headline to continue reading.]]
Posted in San Diego Biotech News, Syndication, Xconomy | Comments Off
Wednesday, July 1st, 2009
Source: Xconomy San Diego
San Diego-based Illumina, the maker of genetic analysis tools for biologists, said today that its second-quarter sales fell short of the company’s forecast. Illumina (NASDAQ: ILMN), in a...
[[Click headline to continue reading.]]
Posted in San Diego Biotech News, Syndication, Xconomy | Comments Off
Wednesday, July 1st, 2009
Source: San Diego Union Tribune
The Food and Drug Administration will require two smoking-cessation drugs, Chantix and Zyban, to carry the agency's strongest safety warning over side effects including depression and suicidal thoughts.
Posted in San Diego Biotech News, San Diego Union Tribune, Syndication | Comments Off
Wednesday, July 1st, 2009
Source: San Diego Union Tribune
Shares of Acorda Therapeutics Inc. fell Wednesday after the company gave Biogen Idec Inc. overseas rights to the experimental multiple sclerosis drug Fampridine-SR, though investors have been hoping for a buyout, according to a JPMorgan analyst.
Posted in San Diego Biotech News, San Diego Union Tribune, Syndication | Comments Off
Wednesday, July 1st, 2009
Source: Xconomy San Diego
San Diego’s Sequenom, which postponed release of its prenatal test for Down syndrome, disclosed in a filing that the Securities and Exchange Commision has initated an investigation into the...
[[Click headline to continue reading.]]
Posted in San Diego Biotech News, Syndication, Xconomy | Comments Off
Wednesday, July 1st, 2009
Source: Xconomy San Diego
The story around Amira Pharmaceuticals’ experimental drug AP2966 is beginning to get interesting. Yesterday the San Diego-based respiratory drug company said its experimental drug reduced lung...
[[Click headline to continue reading.]]
Posted in San Diego Biotech News, Syndication, Xconomy | Comments Off
Wednesday, July 1st, 2009
Source: San Diego Union Tribune
The San Diego biotech company Vical reported encouraging animal-test results yesterday of a vaccine against H1N1 influenza A — swine flu — less than two months after launching the project.
Posted in San Diego Biotech News, San Diego Union Tribune, Syndication | Comments Off
Tuesday, June 30th, 2009
Source: San Diego Union Tribune
Government experts called for sweeping safety restrictions Tuesday on the most widely used painkiller, including reducing the maximum dose of Tylenol and eliminating prescription drugs such as Vicodin and Percocet.
Posted in San Diego Biotech News, San Diego Union Tribune, Syndication | Comments Off